Cipher Pharmaceuticals Inc.
CPH.TO
TSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -51.08% | -19.36% | -16.35% | -23.48% | 231.89% |
| Total Depreciation and Amortization | 114.59% | -17.67% | -0.34% | 24.06% | 61.88% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 98.94% | 75.08% | 71.45% | 83.16% | -3,508.90% |
| Change in Net Operating Assets | -376.08% | -42.39% | -349.14% | -8.01% | -128.36% |
| Cash from Operations | -12.51% | 29.28% | 2.45% | 49.17% | -0.86% |
| Capital Expenditure | -- | 53.09% | 66.67% | 74.07% | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -98.77% | -85.19% | -77.78% | 100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -101.01% | -19.61% | -40.74% | -98.21% | -209.38% |
| Issuance of Common Stock | 21.09% | 180.37% | 156.04% | 222.73% | 189.47% |
| Repurchase of Common Stock | -691.15% | -562.87% | -331.96% | -179.63% | 74.06% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 7,118.13% | -572.05% | -338.93% | -174.27% | 80.42% |
| Foreign Exchange rate Adjustments | -45.75% | 18.32% | 143.51% | 185.36% | 123.94% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -322.89% | -4.12% | -26.11% | 32.59% | 23.29% |
